AMP579, an adenosine A1 and A2A receptor agonist, limits infarct size in rabbit heart in vivo when given at reperfusion:: Role of A2A receptor activation

被引：0
作者：
Baxter, GF [1 ]
Kis, A [1 ]
Yellon, DM [1 ]
机构：
[1] UCL Hosp & Med Sch, Hatter Inst, London WC1E 6DB, England
来源：
BRITISH JOURNAL OF PHARMACOLOGY | 2001年 / 133卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
8P
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Postconditioning reduces infarct size via activation of adenosine A2A and A3 receptor subtypes
    Kin, AJZH
    Lofye, MY
    Amerson, BS
    Halkos, ME
    Kerendi, F
    Zhao, ZQ
    Guyton, RA
    Vinten-Johansen, J
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2005, 38 (05) : 812 - 812
  • [22] Pharmacological characterization of AMP 579, a novel adenosine A1/A2 receptor agonist and cardioprotective
    Merkel, L
    Rojas, CJ
    Jarvis, MF
    Cox, BF
    Fink, C
    Smits, GJ
    Spada, AP
    Perrone, MH
    Clark, KL
    DRUG DEVELOPMENT RESEARCH, 1998, 45 (01) : 30 - 43
  • [23] Cardioprotective effects of the novel adenosine A1/A2 receptor agonist, AMP 579.
    McVey, M
    Smits, GJ
    Cox, BF
    Perrone, MH
    Clark, KL
    FASEB JOURNAL, 1998, 12 (04) : A78 - A78
  • [24] A2A adenosine receptor but not A1 receptor stimulation reduces food intake in rats
    Spies, O
    Krügel, U
    Kittner, H
    Illes, P
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2002, 365 : R33 - R33
  • [25] Pharmacological postconditioning of the rabbit heart with non-selective, A1, A2A and A3 adenosine receptor agonists
    Bibli, Sophia-Iris
    Iliodromitis, Efstathios K.
    Lambertucci, Catia
    Zoga, Anastasia
    Lougiakis, Nikolaos
    Dagres, Nikolaos
    Volpini, Rosaria
    Dal Ben, Diego
    Kremastinos, Dimitrios Th.
    Kakoulidou, Anna Tsantili
    Cristalli, Gloria
    Andreadou, Ioanna
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2014, 66 (08) : 1140 - 1149
  • [26] Pharmacological preconditioning with adenosine A1 receptor agonist suppresses cellular immune response by an A2A receptor dependent mechanism
    Naamani, Oshri
    Chaimovitz, Cidio
    Douvdevani, Amos
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2014, 20 (01) : 205 - 212
  • [27] Apoptosis regression via tnfa reduction in the amygdala concurently to infarct size limitation with an A2A adenosine receptor agonist
    Boucher, M
    Wann, BP
    Kaloustian, S
    Cardinal, R
    Godbout, R
    Rousseau, G
    JOURNAL OF HYPERTENSION, 2005, 23 : S357 - S357
  • [28] The second extracellular loop of the adenosine A2A and A2B receptor: role in receptor activation
    Seibt, Benjamin F.
    Schiedel, Anke C.
    Mueller, Christa E.
    PURINERGIC SIGNALLING, 2010, 6 : 37 - 37
  • [29] Administration of an adenosine A2A receptor agonist (ATL-146e) significantly reduces infarct size in a canine model of coronary occlusion and reperfusion
    Glover, DK
    Ruiz, M
    Riou, LM
    Takehana, K
    Smith, PW
    Rieger, JM
    Macdonald, TL
    Watson, DD
    Linden, J
    Beller, GA
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 37 (02) : 324S - 324S
  • [30] A1 and A2a adenosine receptor gene expression during cardiovascular aging
    Perlini, S
    Arosio, B
    Palladini, G
    Vergani, C
    Annoni, G
    Ferrari, AU
    EUROPEAN HEART JOURNAL, 2002, 23 : 446 - 446
12345